Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.38 billion in 2021. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.
Year founded2007
Served areaWorldwide
Headcount33,106
HeadquartersRellinghauser Straße 1-11, 45128 Essen – Germany
Date | Trading entity / Person | Association | Trade type | Volume | Average price |
---|---|---|---|---|---|
19.12.22 | Wessel, Thomas | Board | Buy | 54,075.00 € | 19.12.22 |
14.11.22 | Kullmann, Christian | Board | Buy | 99,090.75 € | 14.11.22 |
01.07.21 | Lorenz-Meyer, Robert | Supervisory board | Sell | 234,540.92 € | 01.07.21 |
30.06.21 | Wessel, Thomas | Board | Buy | 19,810.00 € | 30.06.21 |
24.06.21 | Krüper, Dr. Manfred | Supervisory board | Other | 0.00 € | 24.06.21 |
24.06.21 | Wolf, Ute | Board | Buy | 101,587.68 € | 24.06.21 |
24.06.21 | Kreke Immobilien KG | Close relation | Other | 0.00 € | 24.06.21 |
466,000,000
IPOApril 25, 2013
Designated Sponsor(s)Commerzbank AG
Stock exchange(s)Frankfurt Stock Exchange